Related references
Note: Only part of the references are listed.Bioengineering Virus-Like Particles as Vaccines
Linda H. L. Lua et al.
BIOTECHNOLOGY AND BIOENGINEERING (2014)
Norovirus gene expression and replication
Lucy G. Thorne et al.
JOURNAL OF GENERAL VIROLOGY (2014)
Comparison of human saliva and synthetic histo-blood group antigens usage as ligands in norovirus-like particle binding and blocking assays
Hanni Uusi-Kerttula et al.
MICROBES AND INFECTION (2014)
High-level expression and immunogenicity of a porcine circovirus type 2 capsid protein through codon optimization in Pichia pastoris
Yabin Tu et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2013)
Characterization and immunogenicity of norovirus capsid-derived virus-like particles purified by anion exchange chromatography
L. Huhti et al.
ARCHIVES OF VIROLOGY (2013)
Applications of recombinant Pichia pastoris in the healthcare industry
Daniel Weinacker et al.
BRAZILIAN JOURNAL OF MICROBIOLOGY (2013)
Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis
Charles Richardson et al.
EXPERT REVIEW OF VACCINES (2013)
The effect of α-mating factor secretion signal mutations on recombinant protein expression in Pichia pastoris
Geoff P. Lin-Cereghino et al.
GENE (2013)
Norwalk Virus Minor Capsid Protein VP2 Associates within the VP1 Shell Domain
Sompong Vongpunsawad et al.
JOURNAL OF VIROLOGY (2013)
Construction and Characterization of Virus-Like Particles: A Review
Andris Zeltins
MOLECULAR BIOTECHNOLOGY (2013)
Norovirus P Particle Efficiently Elicits Innate, Humoral and Cellular Immunity
Hao Fang et al.
PLOS ONE (2013)
Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies
Shailendra Mani et al.
PLOS ONE (2013)
Production and characterization of scFvA33T1, an immunoRNase targeting colon cancer cells
Jaime Tome-Amat et al.
FEBS JOURNAL (2012)
Purification of norovirus-like particles (VLPs) by ion exchange chromatography
Tiia Koho et al.
JOURNAL OF VIROLOGICAL METHODS (2012)
Production and characterization of virus-like particles and the P domain protein of GII.4 norovirus
Tiia Koho et al.
JOURNAL OF VIROLOGICAL METHODS (2012)
Production and characterization of a colon cancer-specific immunotoxin based on the fungal ribotoxin -sarcin
Nelson Carreras-Sangra et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2012)
Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development
Natasha Kushnir et al.
VACCINE (2012)
Expression and Purification of cGMP grade NY-ESO-1 for Clinical Trials
Adam J. Lowe et al.
BIOTECHNOLOGY PROGRESS (2011)
Norovirus P Particle, a Novel Platform for Vaccine Development and Antibody Production
Ming Tan et al.
JOURNAL OF VIROLOGY (2011)
Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the Hepatitis B surface antigen
Heinrich Luensdorf et al.
MICROBIAL CELL FACTORIES (2011)
Norovirus-host interaction: Multi-selections by human histo-blood group antigens
Ming Tan et al.
TRENDS IN MICROBIOLOGY (2011)
Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis
Vesna Blazevic et al.
VACCINE (2011)
Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles
Ming Tan et al.
VIROLOGY (2011)
A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles
L. Huhti et al.
ARCHIVES OF VIROLOGY (2010)
Coming of age of virus-like particle vaccines
Gary T. Jennings et al.
BIOLOGICAL CHEMISTRY (2008)
An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles
Luca Santi et al.
VACCINE (2008)
Noroviral P particle: Structure, function and applications in virus-host interaction
Ming Tan et al.
VIROLOGY (2008)
Virus-like particles-flexible platforms for vaccine development
Bryce Chackerian
EXPERT REVIEW OF VACCINES (2007)
Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN (vol 178, pg 2361, 2007)
S. Hervas-Stubbs et al.
JOURNAL OF IMMUNOLOGY (2007)
Norovirus capsid protein expressed in yeast forms virus-like particles and stimulates systemic and mucosal immunity in mice following an oral administration of raw yeast extracts
Ming Xia et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
Virus-like particles: Passport to immune recognition
Elizabeth V. L. Grgacic et al.
METHODS (2006)
Norovirus protein structure and function
ME Hardy
FEMS MICROBIOLOGY LETTERS (2005)
The P domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors
M Tan et al.
JOURNAL OF VIROLOGY (2005)
Stabilization of human papillomavirus virus-like particles by non-ionic surfactants
L Shi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Recombinant HIV-1 Pr55gag virus-like particles:: potent stimulators of innate and acquired immune responses
L Deml et al.
MOLECULAR IMMUNOLOGY (2005)
Size-dependent immunogenicity: Therapeutic and protective properties of nano-vaccines against tumors
T Fifis et al.
JOURNAL OF IMMUNOLOGY (2004)
An optimized fermentation process for high-level production of a single-chain Fv antibody fragment in Pichia pastoris
LM Damasceno et al.
PROTEIN EXPRESSION AND PURIFICATION (2004)
Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens:: Identification of 4 distinct strain-specific patterns
PW Huang et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Mutations within the P2 domain of norovirus capsid affect binding to human histo-blood group antigens: Evidence for a binding pocket
M Tan et al.
JOURNAL OF VIROLOGY (2003)
Rapid detection of lytic antimicrobial activity against yeast and filamentous fungi
SN Jewell et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2002)
Share Paper
